Journal
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume 19, Issue 11, Pages E689-E698Publisher
CIG MEDIA GROUP, LP
DOI: 10.1016/j.clml.2019.08.011
Keywords
Exportin 1; Karyopherins; Leukemia; Multiple myeloma; Selinexor
Categories
Ask authors/readers for more resources
The correct localization of molecules between nucleus and cytoplasm is fundamental for cellular homeostasis and is controlled by a bidirectional transport system. Exportin 1 (XPO1) regulates the passage of numerous cancer-related proteins. In this review, we summarize the development of a novel class of antitumor agents, known as selective inhibitors of nuclear export (SINEs). We report results of preclinical studies and clinical trials, and discuss the mechanism of action of SINEs and their effects in multiple myeloma, non-Hodgkin lymphomas, lymphoblastic leukemia, and acute and chronic myeloid leukemia. In the future, the numerous experimental studies currently underway will allow us to define the role of SINEs and will possibly permit these substances to be introduced into daily clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available